FOLFOX-6 PLUS IMATINIB, BEVACIZUMAB AND CETUXIMAB IN ADVANCED UNTREATED COLORECTAL CANCER

被引：0
|
作者：
Andretta, V [1 ]
Bennicelli, E. [1 ]
Pessino, A. [1 ]
Caprioni, F. [1 ]
Decian, F. [1 ]
Di Benedetto, M. [1 ]
Sobrero, A. [1 ]
机构：
[1] Azienda Osped Univ San Martino Genova, Genoa, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [1] A triple combination of Imatinib, Bevacizumab and Cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer
    Pessino, A.
    Andretta, V.
    Guglielmi, A.
    Mammoliti, S.
    Caprioni, F.
    Fornarini, G.
    Comandini, D.
    Sciallero, S.
    Ansaldi, F.
    Sobrero, A.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 344 - 344
  • [2] Phase II trial of imatinib, bevacizumab and cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer
    Sobrero, A. F.
    Bennicelli, E.
    Pessino, A.
    Guglielmi, A.
    Mammoliti, S.
    Caprioni, F.
    Fornarini, G.
    Comandini, D.
    Sciallero, S.
    Ansaldi, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Folfox-4+Cetuximab in untreated patients with advanced colorectal cancer
    Colucci, G.
    Giuliani, F.
    Garufi, C.
    Mattioli, R.
    Mallamaci, R.
    Pezzella, G.
    Lopez, M.
    Tuveri, G.
    Maiello, E.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI47 - XI48
  • [4] FOLFOX plus cetuximab in first-line therapy of advanced colorectal cancer
    Ehrenberg, Roland
    Halama, Niels
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [5] Phase II trial of FOLFOX6, bevacizumab and cetuximab in patients with Colorectal Cancer
    Ocean, A. J.
    O'Brien, K.
    Lee, J.
    Matthews, N.
    Holloway, S.
    Christos, P.
    Kung, T. S.
    Kaubisch, A.
    Chen, H.
    Wadler, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Cetuximab plus FOLFOX 6 as first line therapy for metastatic colorectal cancer
    Scott, J
    Dakhil, S
    Cosgriff, T
    Pink, C
    Butler, B
    Boccia, RV
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 297S - 297S
  • [7] Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the Literature
    Funasaka, Chikako
    Kanemasa, Yusuke
    Shimoyama, Tatsu
    Ohta, Akihito
    Omuro, Yasushi
    [J]. CASE REPORTS IN ONCOLOGY, 2019, 12 (02): : 657 - 665
  • [8] Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy
    Takahiro Horimatsu
    Shin’ichi Miyamoto
    Shuko Morita
    Yoko Mashimo
    Yasumasa Ezoe
    Manabu Muto
    Tsutomu Chiba
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 68 : 263 - 266
  • [9] Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy
    Horimatsu, Takahiro
    Miyamoto, Shin'ichi
    Morita, Shuko
    Mashimo, Yoko
    Ezoe, Yasumasa
    Muto, Manabu
    Chiba, Tsutomu
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 263 - 266
  • [10] CHARTA: FOLFOX/Bevacizumab plus /- Irinotecan in advanced colorectal cancer - long term outcome
    Meinert, F.
    Schmoll, H. -J
    Garlipp, B.
    Junghanss, C.
    Leithaeuser, M.
    Vogel, A.
    Schaefers, M.
    Kaiser, U.
    Hoeffkes, H. -G
    Florschuetz, A.
    Ruessel, J.
    Kanzler, S.
    Edelmann, T.
    Forstbauer, H.
    Goehler, T.
    Hannig, C., V
    Hildebrandt, B.
    Steighardt, J.
    Cygon, F.
    Stein, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 245 - 245
12345